BigHat Biosciences
San Mateo
About BigHat Biosciences
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $99.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2022)
- Website: bighatbio.com
- Phone: 650-489-1337
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bighat-biosciences-52018 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.